Invasive Ductal Breast Carcinoma Active Not Recruiting Phase 2 / 3 Trials for Paclitaxel (DB01229)

Also known as: Invasive Ductal Breast Cancer / Carcinoma, Ductal, Breast / Infiltrating ductular carcinoma / Breast ductal cancer invasive / Breast ductal cancer infiltrating / Infiltrating ductal breast cancer

IndicationStatusPhase
DBCOND0047004 (Invasive Ductal Breast Carcinoma)Active Not Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02221999Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer PatientsTreatment